Clifton, NJ, United States of America

Stephen B Ferguson

This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2001.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stephen B. Ferguson

Introduction

Stephen B. Ferguson is an accomplished inventor based in Clifton, NJ (US). He has made significant contributions to the field of retinoid compounds, particularly with his innovative patent related to trienoic retinoids. His work is recognized for its potential applications in various scientific and medical fields.

Latest Patents

Ferguson holds a patent for 7-aryl-6(Z)-heptatrienoic acid retinamides, which are novel trienoic retinoid compounds. This patent showcases his expertise in developing unique chemical compounds that may have important implications in research and therapeutic applications. He has 1 patent to his name, reflecting his innovative contributions to the field.

Career Highlights

Stephen B. Ferguson is associated with Hoffmann-La Roche Inc., a leading global healthcare company. His role at the company has allowed him to collaborate with other talented professionals and contribute to groundbreaking research in the pharmaceutical industry. His work has been instrumental in advancing the understanding of retinoid compounds.

Collaborations

Ferguson has worked alongside notable colleagues, including Louise H. Foley and Allen John Lovey. These collaborations have enriched his research and have led to the development of innovative solutions in the field of retinoid compounds.

Conclusion

Stephen B. Ferguson's contributions to the field of retinoid compounds highlight his innovative spirit and dedication to scientific advancement. His patent and collaborations reflect his commitment to pushing the boundaries of research and development in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…